Jiangxi Renhe Zhongfang Pharmaceutical Co., Ltd.

Jiangxi Renhe Zhongfang Pharmaceutical Co., Ltd. is located in Zhangshu City, the Chinese Medicine Capital, where it is said that 'No medicine is complete without Zhangshu, and no medicine is effective without Zhangshu.' The company was established on November 18, 2009, and is a pharmaceutical wholesale company under the listed company Renhe Pharmaceutical Co., Ltd. (Stock Code: 000650). It is a vice president unit of the China Pharmaceutical Material Association and the honorary president unit of the Single-member Pharmacy Branch of the China Pharmaceutical Material Association. The company's address is No. 36 Renhe Road, Zhangshu City, Jiangxi Province. The company's business covers the wholesale of Traditional Chinese Medicine (TCM) decoction pieces, proprietary Chinese medicines, chemical drug APIs and their preparations, antibiotic APIs and their preparations, biochemical drugs, pre-packaged food, and health food wholesale and retail. It also sells Class I and II medical devices, disinfection products, and cosmetics. Renhe Zhongfang Company adheres to the purpose of 'Serving Human Health' and focuses on achieving the strategic goal of the OTC market*. It has established a marketing network covering 30 provinces, municipalities, and autonomous regions across the country, implements a strict regional protection marketing model, and has established a scientific management system centered on market protection, price maintenance, and promotional support to ensure long-term stability of the market order and long-term interests of terminal customers. The company currently has 298 products on the market in more than ten major series, including cold and anti-inflammatory, pediatric, gynecological, motor nerve, digestive system, and tonic products. It has 52 products in the National Essential Medicines List and 26 nationally exclusive products. It continuously builds the 'Shanliang' eye care brand series, 'Mi'aka' pediatric brand series, 'Kekuaihao' cough brand series, 'Qinghuo' brand, tonic product line, and chronic disease product line, known as 'Four Brands and Two Lines'. In 2023, sales exceeded 6.5 billion yuan.